MCC
PCRX icon

Malaga Cove Capital’s Pacira BioSciences PCRX Stock Holding History

Malaga Cove Capital’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-19,713
Closed -$750K – 161
2019
Q3 		$750K Sell
19,713
-1,658
-8% -$66.2K 0.51% 79
2019
Q2 		$929K Sell
21,371
-775
-3% -$32.9K 0.6% 59
2019
Q1 		$843K Hold
22,146
– – 0.52% 65
2018
Q4 		$924K Sell
22,146
-1,500
-6% -$70K 0.64% 46
2018
Q3 		$1.17M Buy
23,646
+764
+3% +$33K 0.63% 49
2018
Q2 		$733K Sell
22,882
-923
-4% -$31.9K 0.37% 87
2018
Q1 		$742K Buy
23,805
+3,118
+15% +$111K 0.4% 73
2017
Q4 		$944K Buy
20,687
+78
+0.4% +$3.09K 0.53% 61
2017
Q3 		$777K Buy
20,609
+12,877
+167% +$518K 0.45% 68
2017
Q2 		$373K Buy
+7,732
New +$359K 0.22% 92

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Malaga Cove Capital's PCRX Position: Q4 2019 in Review

Malaga Cove Capital sold out of Pacira BioSciences (PCRX) in Q4 2019, closing a stake of 19,713 shares — an estimated $750K sold.

Malaga Cove Capital first reported a position in PCRX in Q2 2017 and held it in 10 quarters. The position peaked at $1.17M in Q3 2018. 231 funds tracked by Wall St. Rank hold PCRX as of Q4 2019.

  • Malaga Cove Capital reported no remaining Pacira BioSciences position as of Q4 2019 after selling out during the quarter.
  • Malaga Cove Capital sold 19,713 Pacira BioSciences shares in Q4 2019, an estimated $750K.
  • Malaga Cove Capital first reported a position in Pacira BioSciences in Q2 2017 and held it in 10 quarters.
  • Malaga Cove Capital's Pacira BioSciences position peaked at $1.17M in Q3 2018.
  • 231 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2019.

Based on Malaga Cove Capital's 13F filing for Q4 2019, filed 13 Feb 2020.